NSPR Message Board Post 9274980 | InspireMD Inc.
home / stock / nspr / nspr message board
spoko007
(investorshub)
Posted on: Jun/01/2022 22:16:32
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169029053
With only 8.3M shares of the Super Tiny
News, Short Squeeze, Breakout and More Instantly...
-
-Conference call and webcast to be held at 8:30 a.m. EDT- TEL AVIV, Israel, and MIAMI, July 30, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease and stroke prev...
-
Series H warrants exercisable following release of positive outcomes results related to one-year follow-up from the Company’s C-GUARDIANS pivotal trial. Participating warrant holders include Marshall Wace, OrbiMed, Rosalind, Nantahala, Soleus, Velan, and certain InspireMD Board m...
-
Data demonstrate lowest reported primary endpoint event rate of 1.95% through twelve months post-procedure for any carotid stent or embolic protection device pivotal trial Study results to support a Premarket Approval (PMA) application to FDA in H2 2024 U.S. commercial launch of...